KDP

Keurig Dr Pepper

$30.37

-1.04%
Oct 2, 2026
Bobby Quantitative Model
Keurig Dr Pepper Inc. is a North American beverage powerhouse formed by the 2018 merger of Keurig Green Mountain and Dr Pepper Snapple, manufacturing and distributing single-serve coffee systems and pods under Keurig and Green Mountain, alongside ready-to-drink flavored beverages including Dr Pepper, Snapple, and Canada Dry. The company occupies a distinctive dual-platform position in the Consumer Defensive sector, straddling the at-home coffee category and the flavored carbonated soft drink market, giving it exposure to both morning coffee rituals and all-day refreshment occasions. The dominant investor narrative in 2026 centers on the transformative $18 billion cash acquisition of JDE Peet's, completed in April 2026, and the announced plan to split into two separately listed entities in early 2027 — one focused on North American refreshment beverages and the other on global coffee. This strategic separation, combined with the company's defensive cash-generative profile and a 3.3% dividend yield, has attracted income-oriented and event-driven investors, though the substantial debt taken on to fund the JDE Peet's deal and the complexity of executing a dual-listing separation remain key points of debate.

People also watch

The Coca-Cola Company

The Coca-Cola Company

KO

Analysis
PepsiCo

PepsiCo

PEP

Analysis
Monster Beverage

Monster Beverage

MNST

Analysis
Coca-Cola Consolidated, Inc.

Coca-Cola Consolidated, Inc.

COKE

Analysis
Primo Brands Corporation

Primo Brands Corporation

PRMB

Analysis

BobbyInvestment Opinion: Should I buy KDP Today?

KDP warrants a Hold rating with a constructive bias, reflecting a balanced risk-reward profile. The consensus analyst recommendation is Buy with a mean of 1.83 and an average target price of $36.21, implying 13.3% upside, but the wide target range of $29 to $42 and the recent margin deterioration argue for caution until integration progress is clearer. The core thesis is that KDP offers a defensive, dividend-paying way to play a potential earnings recovery from the JDE Peet's acquisition, but execution risks are high.

The supporting evidence is mixed but leans positive on valuation: the forward PE of 12.61x is well below the trailing 18.31x and the sector average in the low-to-mid 20s, while the PEG ratio of 0.41 signals undervaluation relative to growth. Revenue growth of 9.38% YoY in Q1 2026 is solid, and the 3.29% dividend yield with a 60.13% payout ratio provides income. However, net margin has compressed to 6.79% from 14.22%, free cash flow has fallen to $165 million in Q1, and the debt-to-equity ratio of 0.633 reflects the acquisition burden. The stock's 24.08% one-year gain already captures some optimism, and the 13.3% upside to the average target is modest for the risk involved.

The biggest risks that could invalidate the thesis are: (1) a failure to realize the expected 45% EPS growth implied by the forward PE, which would make the current multiple look expensive; (2) further margin erosion if interest expenses remain elevated and input costs rise; and (3) execution missteps in the 2027 corporate split. The rating would upgrade to Buy if forward EPS estimates are met or exceeded and net margin stabilizes above 10%, or downgrade to Sell if revenue growth decelerates below 5% or if the split is delayed beyond 2027. Relative to its own history and peers, KDP appears undervalued on a forward basis but fairly valued on trailing metrics, suggesting the market is pricing in a successful integration.

Sign up to view all

KDP 12-Month Price Forecast

KDP presents a classic event-driven investment case where the outcome hinges on the successful integration of JDE Peet's and the execution of the 2027 corporate split. The forward valuation is undeniably attractive at 12.61x earnings if the projected 45% EPS growth materializes, and the 3.29% dividend yield provides a margin of safety for income investors. However, the sharp deterioration in net margin to 6.79% and the collapse in free cash flow to $165 million in Q1 2026 are red flags that cannot be ignored, and the recent 10.15 percentage point underperformance versus SPY suggests the market is skeptical. I would upgrade to bullish if Q3 2026 results show net margin recovering above 10% and free cash flow returning to historical levels, or downgrade to bearish if forward EPS estimates are cut or the split is delayed beyond 2027.

Historical Price
Current Price $30.37
Average Target $36.00
High Target $42.00
Low Target $24.88

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Keurig Dr Pepper's 12-month outlook, with a consensus price target around $36.21 and implied upside of +19.2% versus the current price.

Average Target

$36.21

0 analysts

Implied Upside

+19.2%

vs. current price

Analyst Count

—

covering this stock

Price Range

$29 - $42

Analyst target range

KDP is covered by 17 analysts with a consensus recommendation of "Buy" and a recommendation mean of 1.83 (on a scale where 1.0 is Strong Buy and 5.0 is Strong Sell), indicating a moderately bullish consensus. The average price target of $36.21 implies approximately 13.3% upside from the current price of $31.95, while the estimated average EPS of $3.07 for the forward year suggests the analyst community expects substantial earnings recovery from the trailing EPS of $0.055. The consensus leans constructive but not aggressively bullish, with the recommendation mean of 1.83 reflecting a blend of strong buy ratings from firms like Citigroup, UBS, and JP Morgan, tempered by more neutral stances from Evercore ISI and BNP Paribas. The estimated revenue average of $33.96 billion for the forward year represents a massive step-up from the current run-rate, reflecting the full consolidation of JDE Peet's.

The target price range spans from a low of $29.00 to a high of $42.00, a spread of $13.00 or approximately 45% of the low target, signaling meaningful uncertainty about the company's trajectory. The high target of $42.00 implies roughly 31.5% upside and likely assumes successful integration of JDE Peet's, multiple expansion as leverage declines, and a clean execution of the 2027 corporate separation that unlocks sum-of-the-parts value. The low target of $29.00, which represents about 9.2% downside from the current price, likely prices in integration challenges, margin compression from rising interest expenses, and potential delays or complications in the dual-listing process. Institutional ratings activity shows a predominantly constructive tone, with Barclays upgrading from Equal Weight to Overweight in June 2026 and BNP Paribas upgrading from Underperform to Neutral in April 2026, while Citigroup, JP Morgan, and UBS have maintained Buy or Overweight ratings through mid-2026. The absence of any recent downgrades, combined with the clustering of ratings in the Buy/Overweight camp, suggests that despite the wide target spread, the institutional consensus is that the risk-reward is skewed to the upside for patient investors willing to look through the near-term integration noise.

Drowning in data?

Find the real signal!

Bulls vs Bears: KDP Investment Factors

The bull case rests on KDP's attractive forward valuation (12.6x PE), accelerating revenue growth (9.4% YoY), and a consensus Buy rating with 13.3% upside to the average target. The bear case centers on the sharp net margin compression to 6.79%, a debt-laden balance sheet from the $18 billion JDE Peet's acquisition, and recent negative momentum that has seen the stock underperform SPY by over 10 percentage points in three months. Currently, the bear evidence carries more weight because the margin deterioration and cash flow decline are concrete, reported numbers, while the bull case relies on future earnings accretion that has yet to materialize. The single most important tension is whether the JDE Peet's integration and 2027 split will unlock the anticipated 45% EPS growth implied by the forward PE, or whether integration costs and leverage will continue to suppress profitability. If forward EPS estimates hold, the stock is undervalued; if they are revised down, the current price may be fair or even rich.

Bullish

  • Forward PE of 12.6x implies deep value: KDP trades at a forward PE of 12.61x versus a trailing PE of 18.31x, implying the market expects roughly 45% EPS expansion to $3.07 next year. This wide gap suggests the stock is pricing in significant earnings accretion from the JDE Peet's acquisition, and if that materializes, the shares could re-rate meaningfully higher.
  • Revenue growth accelerating to 9.4% YoY: Q1 2026 revenue of $3.976 billion grew 9.38% year-over-year, following roughly 10.5% growth in Q4 2025 and 10.7% in Q3 2025. This consistent high-single-digit to low-double-digit cadence demonstrates pricing power and volume resilience despite a challenging consumer environment.
  • Analyst consensus Buy with 13.3% upside: 17 analysts rate KDP a Buy with a mean recommendation of 1.83 and an average target price of $36.21, implying 13.3% upside from $31.95. The high target of $42.00 suggests 31.5% upside if the JDE Peet's integration and 2027 split execute cleanly.
  • Defensive low-beta profile with 3.3% yield: KDP's beta of 0.414 makes it roughly 59% less volatile than the broader market, ideal for risk-averse investors. The 3.29% dividend yield, covered by a 60.13% payout ratio, provides steady income while the company digests its acquisition debt.

Bearish

  • Net margin collapsed to 6.79% in Q1: Q1 2026 net income fell to $270 million from $517 million a year earlier, slashing net margin to 6.79% from 14.22%. The decline was driven by interest expense surging to $281 million from $119 million due to JDE Peet's acquisition debt, and a higher effective tax rate.
  • Debt-funded acquisition strains balance sheet: The $18 billion cash acquisition of JDE Peet's pushed debt-to-equity to 0.633 and left the current ratio at a weak 0.635, meaning current liabilities exceed current assets. Free cash flow fell to $165 million in Q1 2026 from $890 million a year earlier, limiting financial flexibility.
  • Recent momentum has turned negative: Despite a 24.08% one-year gain, KDP has declined 0.79% over the past month and 4.34% over three months, underperforming SPY by 1.48 and 10.15 percentage points respectively. This deceleration suggests the post-acquisition rally has stalled and near-term resistance at $33.82 may cap upside.
  • Execution risk on 2027 corporate split: The planned separation into two US-listed entities by early 2027 introduces significant operational complexity. Any delay, unfavorable tax treatment, or value leakage from dis-synergies could pressure the shares, as reflected in the wide analyst target range of $29 to $42.

KDP Technical Analysis

KDP is in a sustained recovery uptrend, with the current price of $31.95 representing a 24.08% gain over the trailing twelve months, significantly outpacing the S&P 500's 17.22% advance over the same period. The stock is trading at approximately 79.2% of its 52-week range, calculated as ($31.95 - $24.88) / ($33.82 - $24.88), positioning it in the upper quartile of its annual band but still roughly 5.5% below the 52-week high of $33.82. This positioning suggests the stock retains upside momentum without being acutely overextended, though the proximity to the upper range warrants vigilance for resistance pressure. The 1-year relative strength versus SPY stands at +6.86 percentage points, confirming genuine outperformance rather than merely riding broad market beta.

Short-term momentum has decelerated meaningfully, with the 1-month price change at -0.79% and the 3-month change at -4.34%, both diverging sharply from the positive 1-year and 6-month (+21.81%) trends. This divergence signals a consolidation phase within a broader uptrend, potentially a healthy digestion of the sharp April-to-June rally that saw the stock surge from roughly $25.31 on April 2 to a peak of $33.50 by June 29. The 1-month relative strength versus SPY is -1.48 percentage points and the 3-month relative strength is -10.15 percentage points, indicating meaningful recent underperformance against the benchmark. The most recent session showed a sharp +3.47% single-day gain on elevated volume of 8.85 million shares, which could mark the beginning of a momentum reversal back toward the longer-term trend.

Key technical support is anchored at the 52-week low of $24.88, with intermediate support likely forming around the $29.00-$30.00 zone where the stock consolidated in July and August. Resistance is defined by the 52-week high of $33.82, and a decisive breakout above this level would signal renewed bullish conviction and potentially open the door to the analyst high target of $42.00. Conversely, a breakdown below the $29.00 support area would threaten the recovery trend and could expose the stock to a retest of the $24.88 low. The beta of 0.414 is notably low, indicating the stock is roughly 59% less volatile than the broader market, which makes it an attractive defensive holding but also implies that large price moves require significant fundamental catalysts — consistent with the event-driven nature of the JDE Peet's acquisition and planned corporate split.

Beta

0.41

0.41x market volatility

Max Drawdown

-18.4%

Largest decline past year

52-Week Range

$25-$34

Price range past year

Annual Return

+18.0%

Cumulative gain past year

PeriodKDP ReturnS&P 500
1m-6.8%+0.6%
3m-8.8%+3.3%
6m+20.0%+17.4%
1y+18.0%+15.0%
ytd+9.5%+12.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

KDP Fundamental Analysis

KDP's revenue trajectory is showing encouraging acceleration, with Q1 2026 revenue of $3.976 billion representing 9.38% year-over-year growth from $3.635 billion in Q1 2025. This marks a meaningful reacceleration from the prior-year quarterly cadence, where Q4 2025 revenue of $4.499 billion grew from $4.070 billion in Q4 2024 (approximately 10.5% growth), and Q3 2025 revenue of $4.306 billion exceeded Q3 2024's $3.891 billion by roughly 10.7%. The revenue segment breakdown reveals that Liquid Refreshment Beverages (LRB) dominate at $2.867 billion, followed by K-Cup Pods at $840 million, Appliances at $116 million, and Other Products at $153 million, underscoring the company's heavy reliance on the carbonated soft drink and beverage portfolio. The consistent high-single-digit to low-double-digit growth across recent quarters supports a constructive investment case, particularly as the JDE Peet's integration adds a global coffee platform with additional revenue diversification.

Profitability remains solid but faces some pressure, with Q1 2026 net income of $270 million translating to a net margin of 6.79%, a notable decline from Q1 2025's $517 million net income and 14.22% net margin. The gross margin in Q1 2026 came in at 52.77%, down from 54.61% in Q1 2025, while the trailing twelve-month gross margin stands at 54.20% and the operating margin at 22.00%. The compression in net margin is partly attributable to a sharp increase in interest expense to $281 million in Q1 2026 from $119 million in Q1 2025, reflecting the debt incurred for the JDE Peet's acquisition, as well as a rise in the effective tax rate. Despite this, the company's gross margin remains healthy for the non-alcoholic beverage industry, where scale players typically operate in the 50-60% range, and the operating margin of 22.00% demonstrates underlying pricing power and cost discipline.

Balance sheet metrics reveal a company in a transitional phase, with a debt-to-equity ratio of 0.633 and a current ratio of 0.635, the latter indicating that current liabilities exceed current assets — a common characteristic of beverage companies with strong recurring cash flows but worth monitoring. Free cash flow on a trailing twelve-month basis is $1.581 billion, and the Q1 2026 free cash flow was $165 million, down from $890 million in Q1 2025, largely due to the acquisition-related financing activities that drove net change in cash to $17.672 billion and cash at end of period to $18.716 billion. Return on equity stands at 8.15% and return on assets at 3.38%, both relatively modest but consistent with the capital-intensive nature of the beverage business and the recent balance sheet expansion. The dividend payout ratio of 60.13% and dividend yield of 3.29% indicate a shareholder-return commitment that is well-covered by earnings but leaves limited room for aggressive buybacks until the JDE Peet's debt is digested.

Quarterly Revenue

$7.3B

2026-06

Revenue YoY Growth

+75.6%

YoY Comparison

Gross Margin

41.9%

Latest Quarter

Free Cash Flow

$2.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

U.S. Refreshment Beverages
U.S. Coffee
KDP International
JDE Peet's

Open an Account, get $2 TSLA now!

Valuation Analysis: Is KDP Overvalued?

With positive trailing net income, the PE ratio is the primary valuation metric, and KDP trades at a trailing PE of 18.31x versus a forward PE of 12.61x, implying the market expects significant earnings growth — approximately 45% EPS expansion — over the next twelve months. This wide gap between trailing and forward multiples reflects the anticipated accretion from the JDE Peet's acquisition and the operational streamlining expected ahead of the 2027 corporate split. The PEG ratio of 0.41, well below 1.0, suggests the stock is undervalued relative to its expected earnings growth rate, a signal that may appeal to growth-at-a-reasonable-price investors. The EV/EBITDA of 12.67x and EV/Sales of 4.11x provide additional context, with the EBITDA multiple appearing elevated relative to the PE, partly due to the debt load from the acquisition inflating enterprise value.

Compared to the broader Consumer Defensive sector, where beverage peers often trade at PE multiples in the low-to-mid 20s, KDP's trailing PE of 18.31x represents a discount of roughly 15-25% depending on the specific peer set. The PS ratio of 2.29x is notably low for a branded consumer staples company, reflecting the market's cautious view on the company's margin trajectory and the complexity of the pending separation. The price-to-book ratio of 1.49x is also modest, suggesting the market values the company close to its tangible asset base. This discount to sector averages appears partially justified by the elevated leverage, compressed net margins, and execution risk surrounding the dual-listing plan, but the forward PE of 12.61x suggests that if earnings materialize as expected, the stock could re-rate meaningfully higher.

Historically, KDP's PE ratio has ranged from a low of approximately 13.0x (Q3 2025) to a high of 32.9x (Q1 2026, distorted by the JDE Peet's transaction), with a more typical range of 20-27x over the 2021-2024 period. The current trailing PE of 18.31x sits below the midpoint of this historical band, while the PS ratio of 2.29x is dramatically below the 8-15x range seen from 2021 through early 2026 — though this PS compression is largely a mechanical artifact of the massive revenue base expansion from the acquisition. The price-to-free-cash-flow ratio of 19.11x is near the lower end of its historical range, which historically oscillated between roughly 50x and 220x during periods of heavy investment. This suggests that on a cash flow basis, the stock is trading at a historically attractive valuation, potentially offering a value opportunity if the company successfully executes its strategic transformation.

PE

18.3x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 13x~33x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

12.7x

Enterprise Value Multiple

Investment Risk Disclosure

KDP's financial risk profile has deteriorated meaningfully following the $18 billion cash acquisition of JDE Peet's. The debt-to-equity ratio of 0.633 and a current ratio of 0.635 indicate a leveraged balance sheet with limited short-term liquidity, while interest expense more than doubled to $281 million in Q1 2026 from $119 million a year earlier. This surge directly caused net margin to collapse to 6.79% from 14.22%, and free cash flow fell to $165 million in Q1 2026 from $890 million, leaving less cushion for dividends or debt reduction. The 60.13% dividend payout ratio is manageable but leaves little room for error if earnings remain depressed.

Market and competitive risks are amplified by KDP's premium valuation relative to its own history and the sector. While the trailing PE of 18.31x is below the 20-27x historical range, the EV/EBITDA of 12.67x is elevated due to acquisition debt, and the PS ratio of 2.29x, though low, reflects a revenue base that has ballooned without proportionate profit growth. The beta of 0.414 offers defensive characteristics, but it also means the stock requires significant fundamental catalysts to move higher, and the recent 3-month underperformance of 10.15 percentage points versus SPY suggests waning investor enthusiasm. Competitive threats in both coffee (from private label and premium roasters) and flavored carbonated soft drinks (from Coca-Cola and PepsiCo) could pressure pricing and volumes.

The worst-case scenario for KDP involves a failed integration of JDE Peet's, delays or complications in the 2027 corporate split, and a consumer slowdown that compresses beverage volumes. In this scenario, forward EPS estimates of $3.07 would be revised sharply lower, and the stock could retest its 52-week low of $24.88, representing a 22.1% decline from the current price of $31.95. The analyst low target of $29.00 implies a more moderate 9.2% downside, but if leverage remains elevated and the split is abandoned, the market could apply a distressed multiple, potentially driving the shares below $25. Investors should be prepared for a drawdown of 20-25% in an adverse outcome.

FAQ

The most severe risk is financial: the $18 billion JDE Peet's acquisition pushed debt-to-equity to 0.633 and caused interest expense to more than double to $281 million in Q1 2026, crushing net margin to 6.79% and reducing free cash flow to $165 million. Second, execution risk on the planned 2027 corporate split is high, as any delay or unfavorable structure could destroy value and the wide analyst target range of $29 to $42 reflects this uncertainty. Third, competitive risks in both coffee and flavored carbonated soft drinks could pressure pricing and volumes, especially if private label gains share. Fourth, macro sensitivity is low given the 0.414 beta, but a consumer slowdown could still reduce demand for discretionary beverage purchases. Ranked by severity, the financial and execution risks are most immediate, followed by competitive and macro factors.

Our 12-month forecast for KDP includes three scenarios: a bull case with 25% probability targeting $38-$42 (31.5% upside), a base case with 55% probability targeting $34-$38 (13.3% upside to the average analyst target of $36.21), and a bear case with 20% probability targeting $24.88-$29 (up to 22.1% downside). The base case is most likely, assuming KDP meets consensus EPS of $3.07 and revenue growth stays around 8-10%, with net margin stabilizing near 9-10%. The key assumption behind the base case is that JDE Peet's integration proceeds without major disruptions and the 2027 split remains on track. A breakout above the 52-week high of $33.82 would signal a move toward the bull case, while a breakdown below $29.00 support would increase the probability of the bear case.

KDP appears undervalued on a forward basis but fairly valued on trailing metrics, creating an ambiguous valuation picture. The forward PE of 12.61x is well below the trailing PE of 18.31x and the sector average in the low-to-mid 20s, while the PEG ratio of 0.41 suggests the stock is cheap relative to expected growth. However, the trailing PE of 18.31x is below the historical range of 20-27x, and the EV/EBITDA of 12.67x is elevated due to acquisition debt. The PS ratio of 2.29x is low for a branded consumer staples company, but this reflects the massive revenue base expansion from JDE Peet's. The market appears to be pricing in successful integration and EPS accretion, so if those expectations are met, the stock is undervalued; if not, it could be fairly valued or even overvalued.

KDP offers a mixed risk-reward profile that makes it a reasonable buy for income-focused investors but less compelling for those seeking aggressive growth. The stock trades at $31.95 with a forward PE of 12.61x and a 3.29% dividend yield, and analysts see 13.3% upside to the average target of $36.21. However, the company's net margin collapsed to 6.79% in Q1 2026 from 14.22% a year earlier, and free cash flow fell to $165 million from $890 million, reflecting the burden of the $18 billion JDE Peet's acquisition. The biggest downside risk is a retest of the 52-week low of $24.88, which would represent a 22.1% loss. For long-term investors comfortable with integration risk and a low-beta defensive profile, KDP could be a good buy on weakness, but near-term momentum is negative and the stock has underperformed SPY by 10.15 percentage points over three months.

KDP is better suited for long-term investment than short-term trading, given its low beta of 0.414, defensive consumer staples nature, and event-driven catalysts that will take time to play out. The 3.29% dividend yield and 60.13% payout ratio provide income for patient holders, while the JDE Peet's integration and 2027 corporate split are multi-year stories that require a holding period of at least 18-24 months to fully realize. Short-term traders may find opportunities around earnings or split announcements, but the stock's low volatility and recent negative momentum (down 4.34% over three months) make it less ideal for quick trades. A minimum holding period of two years is recommended to capture the potential EPS accretion and any re-rating from the separation.